Providers often disagree on sepsis risk, study suggests

A third of patient deaths in hospitals include a sepsis diagnosis, according to the CDC, but the disease is widely misdiagnosed — and physicians’ assessments vary widely, according to a study published Dec. 5 in the Journal of Personalized Medicine. 

Advertisement

Sepsis diagnoses are often delayed or incorrect because there isn’t a leading diagnostic test and the disease’s “clinical presentation … is often nonspecific,” the study’s authors wrote, adding that “early diagnosis is largely dependent upon provider suspicion, intuition and clinical judgment.”

In the study, 26 sepsis experts from multiple specialties, including emergency medicine, critical care, laboratory medicine, infectious disease and pharmacy, evaluated sepsis risk in two hypothetical cases. 

The assessments varied greatly, with clinicians’ answers ranging between 10% and 90% in sepsis risk for the same case. The authors concluded a high need for better sepsis diagnostic tools.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.